Pfizer’s Read Finds Reason to Keep Consumer Health Unit

Pfizer Inc. plans to keep its $3.2 billion-a-year consumer health business because the unit will be critical to selling prescription drugs that become over-the-counter products, Chief Executive Officer Ian Read said.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.